In support of these findings, Foxo1/3/4 deletion in osteoblast progenitors reverses the diabetes impact on reducing cancellous bone mass by limiting osteoclastogenesis in mice with T1DM [24]. The gene discussed is FOXO1; the disease is type 1 diabetes mellitus.